Characterization of cell-mediated immunity in long-term survivors of gastric or colorectal cancerMACHADO, I. V; RUIZ DIEZ, C; BLANCA, I et al.The American journal of surgery. 1984, Vol 147, Num 3, pp 334-338, issn 0002-9610Article

Assessment of former and newly developed HBV assays in a third world settingZABALETA, M. E; TORO, F. I; RUIZ, M. E et al.Journal of medical virology. 1992, Vol 38, Num 4, pp 240-245, issn 0146-6615Article

Risk factors for dialysis-associated hepatitis C in VenezuelaMULLER, G. Y; ZABALETA, M. E; ARMINIO, A et al.Kidney international. 1992, Vol 41, Num 4, pp 1055-1058, issn 0085-2538Article

Costo-beneficio de la vacunación contra la hepatitis B en trabajadores de hospitales de Venezuela = Cost-benefits of hepatitis B vaccination in venezuelan hospital workersFERNANDEZ BARBOZA, R; RIVERO, D; ECHEVERRIA, B et al.Boletín de la Oficina sanitaria panamericana. 1991, Vol 111, Num 1, pp 15-23, issn 0030-0632, 9 p.Article

CD3- and CD28-activating pathways in HCV infectionCORADO, J. A; TORO, F. I; BAROJA, M. L et al.Viral immunology. 1994, Vol 7, Num 1, pp 37-40, issn 0882-8245Article

Anti-CD3-activated T cells from chronic nonviremic HBV carriers are hyperreactive to monocytic accessory signalsBAROJA, M. L; SIRIT, F. L; CALDERA, D. J et al.Clinical immunology and immunopathology (Print). 1993, Vol 69, Num 2, pp 180-188, issn 0090-1229Article

Cellular immunity in current active pulmonary tuberculosisANDRADE-ARZABE, R; MACHADO, I. V; FERNANDEZ, B et al.The American review of respiratory disease. 1991, Vol 143, Num 3, pp 496-500, issn 0003-0805Article